Literature DB >> 14685678

[Matrix metalloproteinases and colorectal cancer].

Elke Roeb1, Siegfried Matern.   

Abstract

Malignant tumors have the ability to invade normal tissue and to spread to distant sites giving rise to metastasis, which are major factors in the morbidity and mortality of colorectal cancer. Invasion and metastasis involve attachment of tumor cells to the basement membrane, degradation of the local connective tissue, and penetration and migration through proteolyzed stroma. The key enzymes responsible for ECM breakdown are matrix metalloproteinases (MMPs). To date, 26 MMP genes have been identified in humans, and many are implicated in cancer. ECM degradation by MMPs not only enhances tumor invasion, but also affects tumor cell behavior and leads to cancer progression. This review highlights recent developments with regard to the cellular and molecular mechanisms of MMPs that influence colorectal tumor cell growth, invasion, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685678     DOI: 10.1007/s00063-003-1322-5

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  5 in total

1.  Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.

Authors:  Haiyan Chen; Yeting Hu; Weibo Xiang; Yibo Cai; Zhanhuai Wang; Qian Xiao; Yue Liu; Qiong Li; Kefeng Ding
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Different matrix micro-environments in colon cancer and diverticular disease.

Authors:  U Klinge; R Rosch; K Junge; C J Krones; M Stumpf; P Lynen-Jansen; P R Mertens; V Schumpelick
Journal:  Int J Colorectal Dis       Date:  2006-10-05       Impact factor: 2.796

Review 3.  Colorectal cancer and basement membranes: clinicopathological correlations.

Authors:  Charalampos C Mylonas; Andreas C Lazaris
Journal:  Gastroenterol Res Pract       Date:  2014-12-28       Impact factor: 2.260

4.  MicroRNA-29 Family Suppresses the Invasion of HT1080 Human Fibrosarcoma Cells by Regulating Matrix Metalloproteinase 2 Expression.

Authors:  Jin Hee Kim; Songhee Jeon; Boo Ahn Shin
Journal:  Chonnam Med J       Date:  2017-05-25

5.  MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.

Authors:  Zuo Tao; Huandan Suo; Lei Zhang; Zining Jin; Zhen Wang; Danyu Wang; Ming Wu; Nanxi Peng; Yujie Zhao; Bo Chen
Journal:  Onco Targets Ther       Date:  2020-11-27       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.